Epigral Limited has scheduled a meeting of its Board of Directors for May 2, 2026. The board will review and approve the company’s audited standalone and consolidated financial results for the fourth quarter and the full financial year ended March 31, 2026. Additionally, the directors will consider the recommendation of a final dividend for the shareholders, subject to approval.
Upcoming Board Meeting Details
Epigral Limited has formally announced that its Board of Directors is set to convene on Saturday, May 2, 2026. This meeting will serve as the platform for the management to present the financial performance of the organization for the quarter and year ending March 31, 2026.
Financial Review and Dividend Proposal
During the session, the board will evaluate the audited standalone and consolidated financial results for the final quarter (Jan-Mar) and the entire fiscal year. The board will also take on record the official report provided by the company’s statutory auditors regarding these financial statements.
A significant highlight of the meeting will be the discussion and potential recommendation of a final dividend on equity shares with a face value of Rs. 10/- each. Any dividend payout recommended by the board will be subject to subsequent approvals as required by corporate governance policies.
Source: BSE
